Shanghai INT Medical Instruments Co., Ltd. (HKG:1501)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
33.06
-0.80 (-2.36%)
Oct 2, 2026, 3:59 PM HKT

HKG:1501 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
1,2001,065851.95752.84585.88464.68
Revenue Growth
12.67%25.06%13.17%28.50%26.08%29.64%
Gross Profit
730.51636.79537.66438.07332.49275.75
Operating Income
317.63258.29212.02161.99129.34144.64
Net Income
218.28206.23180.92151.88130.15142.96
Earnings Per Share
1.221.261.100.920.780.86
EPS Growth
-2.99%14.17%20.10%17.49%-9.38%17.81%

Revenue by Segment

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
ALL Others
448.72304.17163.57160.24133.2681.73
Cardiovascular Interventional Business
885.1876.93771.93641.32497.05411.18
Elimination of Inter-Segment
-133.37-115.63-83.55-48.73-44.43-28.24
Total
1,2001,065851.95752.84585.88464.68

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
1,322650.81551.95434.4528.27640.55
Total Debt
716.38715.96243.6994.7848.8313.4
Net Cash (Debt)
605.65-65.14308.27339.62479.44627.15
Net Cash Growth
---9.23%-29.16%-23.55%-33.27%
Net Cash Per Share
3.22-0.381.811.992.843.76

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
437.4348.11225.54178.15180.4672.76
Capital Expenditures
-67.69-64.48-125.74-168.84-243.21-277.83
Free Cash Flow
369.71283.6399.89.31-62.75-205.07
Free Cash Flow Growth
30.35%184.18%972.35%---

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
60.85%59.77%63.11%58.19%56.75%59.34%
Operating Margin
26.46%24.24%24.89%21.52%22.08%31.13%
Pretax Margin
23.52%24.24%25.05%23.26%24.66%33.51%
Profit Margin
18.18%19.36%21.24%20.18%22.21%30.77%
FCF Margin
30.80%26.62%11.71%1.24%-10.71%-44.13%

Dividends

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Dividend Per Share
0.2600.230-0.2700.2400.260
Dividend Per Share Growth
0%--12.50%-7.69%-8.77%
Dividend Yield
0.79%0.86%-1.06%0.97%1.46%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
23.5122.8926.4729.2332.8321.76
Forward PE
-23.0318.8820.4420.8923.81
P/FCF Ratio
16.3616.6447.97476.97--
PS Ratio
5.044.435.625.907.296.69